Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia; Department of Surgery and Gastroenterology, Queen Elizabeth II Jubilee Hospital, Brisbane, Queensland, Australia.
Department of Surgery and Gastroenterology, Queen Elizabeth II Jubilee Hospital, Brisbane, Queensland, Australia.
Gastrointest Endosc. 2017 Aug;86(2):372-375.e2. doi: 10.1016/j.gie.2016.11.031. Epub 2016 Dec 6.
Optical diagnosis allows for real-time endoscopic assessment of colorectal polyp histology and consists of the resect and discard and diagnose and leave paradigms. This survey assessed patient acceptance of optical diagnosis and their responses to a hypothetical doomsday scenario.
We conducted a 3-month cross-sectional survey of colonoscopy outpatients presenting to an Australian academic endoscopy center.
A total of 981 patients completed the survey (76.0% response rate). The 60.8% of patients who supported resect and discard were more likely to be older men who co-supported diagnose and leave. Fewer patients (49.6%) supported diagnose and leave. A family history of missed cancer diagnosis (odds ratio [OR], 0.59; P = .003) was significantly associated with rejection of resect and discard, and a personal or family history of bowel cancer (OR, 0.7; P = .04) was significantly associated with rejection of diagnose and leave. In the hypothetical scenario of a cancerous polyp incorrectly left in situ leading to stage III disease, 208 (21.2%) patients would definitely ask for financial compensation, 584 (59.5%) were unsure, and 189 (19.3%) would definitely not seek compensation. The patient-proposed median value of compensation sought was $760,000 USD ($1,000,000 AUD; $1 AUD = $0.76 USD). Notably, 18.5% would be willing to give optical diagnosis another chance after this error.
Patient support for optical diagnosis is limited, and those who are not supporters are more likely to seek financial compensation if errors occur.
光学诊断可实时进行结直肠息肉组织学的内镜评估,包括切除并丢弃和诊断并保留这两种模式。本研究评估了患者对光学诊断的接受程度以及他们对假设的世界末日场景的反应。
我们对在澳大利亚学术内镜中心就诊的结肠镜检查门诊患者进行了为期 3 个月的横断面调查。
共有 981 名患者完成了调查(应答率为 76.0%)。支持切除并丢弃的患者中,60.8%是年龄较大的男性,他们也支持诊断并保留。支持诊断并保留的患者较少(49.6%)。有癌症漏诊家族史(比值比 [OR],0.59;P =.003)的患者明显更倾向于拒绝切除并丢弃,有个人或家族结直肠癌史(OR,0.7;P =.04)的患者明显更倾向于拒绝诊断并保留。在一个错误地将癌变息肉留在原位导致 III 期疾病的假设场景中,208 名(21.2%)患者肯定会要求经济赔偿,584 名(59.5%)不确定,189 名(19.3%)肯定不会寻求赔偿。患者提出的赔偿中位数为 76 万美元(100 万澳元;1 澳元=0.76 美元)。值得注意的是,18.5%的患者在发生这种错误后愿意再给光学诊断一次机会。
患者对光学诊断的支持有限,而不支持该诊断的患者如果出现错误更有可能寻求经济赔偿。